Loading...

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer

The histone methyltransferase EZH2, a key epigenetic modifier, is known to be associated with human tumorigenesis. However, the physiological importance of EZH2 and its clinical relevance in endometrial cancer remain unclear. Hence, in the present study, we investigated the expression and function o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Oki, Shinya, Sone, Kenbun, Oda, Katsutoshi, Hamamoto, Ryuji, Ikemura, Masako, Maeda, Daichi, Takeuchi, Makoto, Tanikawa, Michihiro, Mori-Uchino, Mayuyo, Nagasaka, Kazunori, Miyasaka, Aki, Kashiyama, Tomoko, Ikeda, Yuji, Arimoto, Takahide, Kuramoto, Hiroyuki, Wada-Hiraike, Osamu, Kawana, Kei, Fukayama, Masashi, Osuga, Yutaka, Fujii, Tomoyuki
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522273/
https://ncbi.nlm.nih.gov/pubmed/28418882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16316
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!